Lloyd A Rowland insider trades: CytomX Therapeutics (CTMX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Lloyd reports to the SEC
Open-market buys and sales
37 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 18, 2025 | CTMX | ↓ Sell | 10,203 | $0.60 | $6K | Direct | Mar 20, 2025 (2d) |
| Aug 20, 2024 | CTMX | ↓ Sell | 4,181 | $1.23 | $5K | Direct | Aug 22, 2024 (2d) |
| Mar 19, 2024 | CTMX | ↓ Sell | 5,268 | $2.09 | $11K | Direct | Mar 21, 2024 (2d) |
| Dec 20, 2023 | CTMX | ↓ Sell | 4,077 | $1.38 | $6K | Direct | Dec 22, 2023 (2d) |
| Sep 22, 2023 | CTMX | ↓ Sell | 5,486 | $1.30 | $7K | Direct | Sep 22, 2023 (0d) |
| Mar 16, 2023 | CTMX | ↓ Sell | 2,037 | $1.98 | $4K | Direct | Mar 20, 2023 (4d) |
| Jul 20, 2022 | CTMX | ↓ Sell | 5,602 | $1.42 | $8K | Direct | Jul 21, 2022 (1d) |
| Mar 4, 2019 | CTMX | ↑ Buy | 9,000 | $10.33 | $93K | Direct | Mar 5, 2019 (1d) |
| Mar 29, 2012 | AMLN | ↓ Sell10b5-1 | 8,000 | $23.64 | $189K | Direct | Mar 29, 2012 (0d) |
| Aug 18, 2008 | AMLN | ↓ Sell | 100 | $35.00 | $4K | Direct | Aug 20, 2008 (2d) |
| Dec 3, 2007 | AMLN | ↓ Sell | 2,000 | $37.55 | $75K | Direct | Dec 4, 2007 (1d) |
| Nov 1, 2007 | AMLN | ↓ Sell | 2,000 | $44.16 | $88K | Direct | Nov 2, 2007 (1d) |
| Oct 1, 2007 | AMLN | ↓ Sell | 2,000 | $49.67 | $99K | Direct | Oct 2, 2007 (1d) |
| Sep 4, 2007 | AMLN | ↓ Sell | 2,000 | $48.99 | $98K | Direct | Sep 6, 2007 (2d) |
| Aug 1, 2007 | AMLN | ↓ Sell | 2,000 | $46.31 | $93K | Direct | Aug 3, 2007 (2d) |
| Jul 2, 2007 | AMLN | ↓ Sell | 2,000 | $41.00 | $82K | Direct | Jul 3, 2007 (1d) |
| Jun 1, 2007 | AMLN | ↓ Sell | 2,000 | $46.64 | $93K | Direct | Jun 4, 2007 (3d) |
| May 1, 2007 | AMLN | ↓ Sell | 5,000 | $41.50 | $207K | Direct | May 2, 2007 (1d) |
| Apr 2, 2007 | AMLN | ↓ Sell | 2,000 | $36.95 | $74K | Direct | Apr 3, 2007 (1d) |
| Mar 1, 2007 | AMLN | ↓ Sell | 2,000 | $37.39 | $75K | Direct | Mar 2, 2007 (1d) |
| Feb 1, 2007 | AMLN | ↓ Sell | 2,000 | $38.92 | $78K | Direct | Feb 2, 2007 (1d) |
| Jan 3, 2007 | AMLN | ↓ Sell | 2,000 | $36.10 | $72K | Direct | Jan 4, 2007 (1d) |
| Dec 1, 2006 | AMLN | ↓ Sell | 2,000 | $39.39 | $79K | Direct | Dec 5, 2006 (4d) |
| Nov 1, 2006 | AMLN | ↓ Sell | 2,000 | $44.01 | $88K | Direct | Nov 2, 2006 (1d) |
| Oct 2, 2006 | AMLN | ↓ Sell | 2,000 | $43.07 | $86K | Direct | Oct 3, 2006 (1d) |
| Sep 1, 2006 | AMLN | ↓ Sell | 2,000 | $45.21 | $90K | Direct | Sep 6, 2006 (5d) |
| Aug 1, 2006 | AMLN | ↓ Sell | 2,000 | $47.43 | $95K | Direct | Aug 3, 2006 (2d) |
| Jul 3, 2006 | AMLN | ↓ Sell | 2,000 | $48.02 | $96K | Direct | Jul 6, 2006 (3d) |
| Jun 1, 2006 | AMLN | ↓ Sell | 2,000 | $45.57 | $91K | Direct | Jun 2, 2006 (1d) |
| May 1, 2006 | AMLN | ↓ Sell | 2,000 | $43.00 | $86K | Direct | May 2, 2006 (1d) |
| Apr 3, 2006 | AMLN | ↓ Sell | 2,000 | $46.88 | $94K | Direct | Apr 4, 2006 (1d) |
| Mar 1, 2006 | AMLN | ↓ Sell | 3,000 | $43.00 | $129K | Direct | Mar 1, 2006 (0d) |
| Feb 1, 2006 | AMLN | ↓ Sell | 3,000 | $41.71 | $125K | Direct | Feb 3, 2006 (2d) |
| Jan 3, 2006 | AMLN | ↓ Sell | 5,500 | $39.77 | $219K | Direct | Jan 4, 2006 (1d) |
| Dec 1, 2005 | AMLN | ↓ Sell | 2,500 | $37.60 | $94K | Direct | Dec 2, 2005 (1d) |
| Nov 1, 2005 | AMLN | ↓ Sell | 2,500 | $33.10 | $83K | Direct | Nov 2, 2005 (1d) |
| Oct 3, 2005 | AMLN | ↓ Sell | 2,500 | $36.15 | $90K | Direct | Oct 4, 2005 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CTMX insiders
Open-market trades in the last 12 months
About Lloyd A Rowland's insider trades
Lloyd A Rowland is General Counsel at CytomX Therapeutics (CTMX). Since Oct 3, 2005, Lloyd has reported 1 open-market purchase worth $93K and 36 sales worth $2.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
1 sale (6% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include option exercises (34 filings), grants and awards (33 filings), other transactions (2 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CTMX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.